Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia

Leukemia and Lymphoma

Volumn 35, Issue 5-6, 1999, Pages 483-489

  Sacchi, Stefano ^a   Kantarjian, Hagop M ^a   Freireich, Emil J ^a   O' Brien, Susan ^a   Cortes, Jorge ^a   Rios, Mary Beth ^a   Kornblau, Steve ^a   Giles, Francis J ^a   Koller, Charles ^a   Gajewski, James ^a   Talpaz, Moshe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

All trans retinoic acid; Alpha interferon; ATRA; Chronic myelogenous leukemia; CML; Low dose ara C; Severe toxicity

Indexed keywords

ALPHA INTERFERON; CYTARABINE; HYDROXYUREA; RETINOIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASEPTIC NECROSIS; ASTHMA; ATAXIA; BONE PAIN; BRAIN PSEUDOTUMOR; CHEILITIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CYTOGENETICS; DEPRESSION; DIARRHEA; DRUG TOXICITY; ERYTHROCYTE APLASIA; FATIGUE; FEMALE; HEADACHE; HEMATOLOGY; HUMAN; HUMAN CELL; INSOMNIA; LEUKOCYTOSIS; LOW BACK PAIN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MYALGIA; NEUROTOXICITY; PARANOIA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; SIDE EFFECT; SKIN ALLERGY; SYNCOPE; WEIGHT REDUCTION;

EID: 0033400136     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428199909169612     Document Type: Article

References (22)

1. Kantarjian H, Giles FJ, O' Brien SM, Talpaz M. (1998) Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy. Hematology Oncology Clinics of North America 12, 31-79.
2. Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J, for the French Chronic Myeloid Leukemia Study Group (1997) Interferon-alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. N Engl J Med 337, 223-229.
3. Kantarjian HM, O' Brien S, Smith TL, Rios MB, Cortes J, Beran M, Koller C, Giles FJ, Andreeff M, Kornblau S, Giralt S, Keating M, Talpaz, M. (1999) Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low dose cytosine arabinoside. J Clin Oncol 17, 284-292.
4. Huang ME, Ye YC, Chen SR, Chai JR, Jia-Xiang L, Lin Z, Long-jun G, Zhenyi W. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572.
5. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) pilot study. Blood 88, 1390-1398.
6. Sacchi S, Russo D, Avvisati G, Dastoli G, Lazzarino M, Pelicci PG, Bonora MR, Visani G, Grassi C, Iacona I, Luzzi L, Vunzanelli P. (1997) All-trans retinoic acid in hematological malignancies, an update. Haematologica 82, 106-121.
7. Gallagher R, Ahearn G, Thompson D, Streck M, Paietta F, Dutcher J, Wiernik P. (1990) Retinoic acid enhanced neutrophilic differentiation of granulocyte-macrophage progenitors in blastic crisis chronic myelogenous leukemia. Blood 76, 272a.
8. Januszewicz E, Rabizadah E, Maimon Z, Zaizof R, Shaklai M. (1988) Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative diseases: increased sensitivity in blast phase of chronic myeloid leukemia. Pathology 20, 1-6.
9. Sagayadan GE, Peter H, Wiernik PH, Sun N, Ahern G, Thompson D, Hallam SJ, Hu XP, Dutcher JP, Gallagher RE. (1994) Effect of retinoid acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans and 13-cis-retinoic acid in advanced stage disease. Leukemia Res 18, 741-748.
10. Aglietta M, Piacibello W, Stacchini A, Sanavio E, Gavosto F. (1985) In vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis. Leukemia Res 9, 879-883.
11. Nilsson B, Olofssson T, Olsson I. (1984) Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin. Exp Hematol 12, 91-99.
12. Moore M, Mertelsmann R, Pelus I. (1981) Phenotypic evaluation of chronic myeloid leukemia. Blood Cells 7, 217-236.
13. Zheng A, Savolainen ER, Koistinen P. (1996) All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia. Leukemia Res 20, 243-248.
14. Guglielmo P, Stagno F, Cacciola E Jr, Cacciola RR, Impera S, Giustolisi R, Cacciola E. (1995) All-trans retinoic acid (ATRA) induced apoptosis in peripheral freshly isolated chronic myeloid leukemia cells. Blood 86(Suppl 1): 253a.
15. Cortes J, Kantarjian H, O' Brien S, Beran M, Estey E, Keating M, Talpaz M. (1997) A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Leukemia 11, 929-932.
16. Russo D, Regazzi M, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Iacona I, Candoni A, Grattoni R, Galieni P, Rupoli S, Liberati AM, Maiolo AT. (1998) All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. Leukemia 12, 449-454.
17. Kantarjian H, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. (1993) Chronic myelogenous leukemia: A concise update. Blood 82, 691-703.
18. National Cancer Institute. Guidelines for reporting of adverse drug reactions, Bethesda MD, Division of Cancer Treatment, National Cancer Institute, 1988.
19. Kaplan EL, Meier P. (1958) Nonparametric estimation from incomplete observations. J Amer Stat Assoc 53, 457-481.
20. Mantel N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemoter Rep 50, 163-170.
21. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB. (1990) Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med 88: 1-8.
22. Lazzarino M, Corso A, Regazzi MB, Iacona I, Bernasconi C. (1995) Modulation of all-trans retinoic acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-α therapy. Brit J Haemat 90, 928-930.